Innovative Technology for Surgical Solutions
Lumenis is a global leader in medical lasers, with a proven legacy of innovations spanning 50 years. Our long term investment in lasers and energy based technologies result in a continuous flow of novel, state-of-the-art surgical solutions, for improved patient care and clinical outcome across a wide range of specialties.
A new breakthrough patent pending technology that redefines holmium lithotripsy technology as it exists today. The unique Moses technology is designed to significantly reduce retropulsion during lithotripsy, enabling less stone migration and a more efficient procedure.
Moses™ technology includes a proprietary combination of holmium lasers and fibers that optimize holmium energy transmission, allowing the surgeon more control regardless of the working distance between the fiber and the stone.
Lasers are now used in a wide range of surgical specialties and procedures. Lumenis pioneered the introduction of Holmium lasers for surgical use, leveraging the unique advantages of the Holmium wavelength and mode of operation.
Operating at a wavelength of 2.1 microns, is highly absorbed by water and has a shallow penetration depth of approximately 0.4 mm. The shallow penetration depth minimizes the coagulation zone and collateral damage to sensitive surrounding tissue for clean and precise incision and tissue vaporization (also called ablation).
For optimal utilization of laser wavelength characteristics, Lumenis was the first to introduce multi wavelength technology for surgical applications, the VersaPulse® PowerSuite™ 80/100 Dual Wavelength system, with 80 watt of Holmium and 100 watt ofNd:YAG laser power.
A Powerful Combination: The Holmium laser, operating at a wavelength of 2.1 microns, is highly absorbed by water and has a shallow tissue penetration depth, making it highly suitable for operation in fluid environment, with precise incision and vaporization characteristics to minimize collateral thermal damage tosensitive surrounding tissue.
The Lumenis Pulse high power as well as the VersaPulse PowerSuite 100 watt Holmium lasers, paved the way for multiple applications in urology, including the minimally invasive treatment of Benign Prostatic Hyperplasia (BPH). During the Holmium Laser Enucleation of the Prostate (HoLEP) procedure, the prostate lobes are endoscopically separated from the prostate capsule and pushed into the bladder.
The CO2 laser is highly specific for water absorption which means that it operates very superficially. What you see is what you get, with little thermal damage incursion below the surface which could affect tissue function. For this reason, the CO2 laser affords the benefit of more precise cutting and ablation than many other laser types, narrower tissue margins, and heightened safety for your patients.